摘要:
In a method for operating an internal combustion engine, a steady-state maximum output torque and a dynamic maximum torque are ascertained. The ascertained steady-state maximum output torque is changed to a resulting steady-state maximum torque by adapting the maximum output torque in such a way that it is equal to or greater than the ascertained dynamic maximum torque.
摘要:
The present invention relates to the use of compounds of the general Formula (XIII): wherein A7 is C═O, C═S, SO2, CH—OR13, C═NR12, or CH2—CHOR13; A8 is C(R14)2, O, S, or NR12; A9 is C═O, C═S, SO2, CH—OR13, C═NR12, or CH2—CHOR13; m is 0, or 1 q is 0, or 1 r is 0, or 1 R12 is H, CH3, CH2—CH3, C6H5, OCH3, OCH2—CH3, OH, or SH; R13 is H, CH3, or CH2—CH3; R14 is H, alkyl, alkoxy, OH, or SH;
摘要翻译:本发明涉及通式(XIII)化合物的用途:其中A 7为C = O,C = S,SO 2,CH-OR 13,C = NR 12或CH 2 -CHOR 13; A8为C(R14)2,O,S或NR12; A9为C = O,C = S,SO2,CH-OR13,C = NR12或CH2-CHOR13; m为0或1 q为0或1 r为0,或1 R 12为H,CH 3,CH 2 -CH 3,C 6 H 5,OCH 3,OCH 2 -CH 3,OH或SH; R 13是H,CH 3或CH 2 -CH 3; R 14是H,烷基,烷氧基,OH或SH;
摘要:
The invention relates to a transmission module for transmitting data in the form of useful digital signals by modulation of a carrier, determined by the useful signals, by means of frequency shift keying. The transmission module contains a PLL circuit with a voltage-controlled oscillator and a controllable frequency divider with a frequency divider control input. The transmission module is designed to induce direct frequency shift keying (DFSK) of the carrier signal by appropriate triggering of the frequency divider with at least two different frequency divider control signals, and it has a modulation data preprocessing unit, which is connected to the frequency divider control input and is designed to weight samples of the same polarity of the useful signals to be transmitted and to fine tune the frequency divider control signal with regard to the frequency deviation to be induced.
摘要:
The present invention relates to compounds of the general formulas (I), (Ia) and (II) and salts and physiologically functional derivatives thereof, wherein the substituents —Y are attached to the 5- or 6-position of the benzazole.
摘要:
A mounting plate for electronic components, including cooling conduits that are integrated into a plate body and that are traversed by a coolant, and a fixing device for mounting the electronic components being located on the plate body. The fixing device includes at least one retaining piece and a first recessed groove or channel that extends in a linear manner in the direction of extension of the mounting plate. A retaining piece, which includes a fixing thread, for securing the component can be inserted into the groove or channel.
摘要:
A patient device (10) having a first interface (20) for the wireless transmission of data from and to an implant and having a second interface (22) for the remote data communication with a central service center and having a third interface (24) different from the first and second interfaces, the third interface (24) being implemented for connecting a programming device to the patient device (10) and the patient device (10) being implemented to relay programming data received via the third interface (24) on the part of a programming device to the first interface (20) and wirelessly transmit it to an implant.
摘要:
The present invention relates to the use of compounds of the general Formula (I): wherein in Formula (I), R is H, alkyl, cycloalkyl, aryl or heteroaryl; R1 is H, alkyl, cycloalkyl, aryl or heteroaryl; R2 is H, alkyl, cycloalkyl, aryl or heteroaryl; A1 and A2 each independently represent an optionally substituted C1-C20-alkyl group which may contain one or more group(s) Z, or a monocyclic or polycyclic optionally substituted aromatic or non-aromatic ring system which may contain one or more group(s) X, and in case of a polycyclic ring system, said system contains at least one aromatic ring; Z is selected from the group consisting of S, O, N, NR4, CO, CO2, CS, SO or SO2 X is selected from the group consisting of S, O, N, NR4, SO or SO2.
摘要翻译:本发明涉及通式(I)的化合物的用途:其中在式(I)中,R为H,烷基,环烷基,芳基或杂芳基; R 1是H,烷基,环烷基,芳基或杂芳基; R 2是H,烷基,环烷基,芳基或杂芳基; A 1和A 2各自独立地表示任选取代的C 1 -C 20 -C 20 - 烷基,其可以含有 一个或多个Z基团或可以含有一个或多个基团X的单环或多环任选取代的芳族或非芳族环系统,并且在多环系统的情况下,所述体系包含至少一个 芳香环 Z选自S,O,N,NR 4,CO,CO 2,CS,SO或SO 2 X 选自S,O,N,NR 4,SO或SO 2。
摘要:
The present invention relates to the use of compounds of the general Formula (XIII): In particular the invention refers to a family of compounds that block the quorum sensing system of Gram-negative bacteria, a process for their manufacture, pharmaceutical compositions containing them and to their use for the treatment and prevention of microbial damages and diseases, in particular for diseases where there is an advantage in inhibiting quorum sensing regulated phenotypes of pathogens.
摘要:
The present invention relates to the use of compounds of the general Formula (XIII): wherein A7 is C═O, C═S, SO2, CH—OR13, C═NR12, or CH2—CHOR13; A8 is C(R14)2, O, S, or NR12; A9 is C═O, C═S, SO2, CH—OR13, C═NR12, or CH2—CHOR13; m is 0, or 1 q is 0, or 1 r is 0, or 1 R12 is H, CH3, CH2—CH3, C6H5, OCH3, OCH2—CH3, OH, or SH; R13 is H, CH3, or CH2—CH3; R14 is H, alkyl, alkoxy, OH, or SH;
摘要翻译:本发明涉及通式(XIII)化合物的用途:其中A 7为CO,CS,SO 2,CH-OR 13, C-NR 12或CH 2 -CHOR 13; A 8是C(R 14)2,O,S或NR 12; A 9是CO,CS,SO 2,CH -OR 13,C-NR 12或CH < 2> -CHOR 13< 13> m为0或1 q为0或1 r为0,或1 R 12为H,CH 3,CH 2 - CH 3,C 6 H 5,OCH 3,OCH 2,-CH 2,CH 3, 3,OH或SH; R 13是H,CH 3或CH 2 -CH 3; R 14是H,烷基,烷氧基,OH或SH;
摘要:
Compounds of formula (I) and salts and physiologically functional derivatives thereof, wherein R2 is attached at the 4- or 5-position of the thiazole ring and is hydrogen, alkyl, halogen, cyano, alkoxy, haloalkoxy, or alkylamino; X independently represents a divalent linkage group selected from S, O, NR4, SO, or SO2; R4 is hydrogen, alkyl, cycloalkyl, cycloalkylalkyl, or heterocyclyl; R1 is attached at the 4- or 5-position of the thiazole ring and independently represents a group of formula (II): wherein the dotted line represents a single or double bond; * indicates the point of attachment to the thiazole ring; and n is 1, 2, or 3. Also disclosed are pharmaceutical compositions comprising the above compounds and method of treatments for cancer and other diseases.
摘要翻译:式(I)化合物及其盐和生理功能衍生物,其中R 2连接在噻唑环的4-或5-位,并且是氢,烷基,卤素,氰基,烷氧基, 卤代烷氧基或烷基氨基; X独立地表示选自S,O,NR 4,SO或SO 2的二价键合基团。 R 4是氢,烷基,环烷基,环烷基烷基或杂环基; R 1连接在噻唑环的4-或5-位,独立地表示式(II)的基团:其中虚线表示单键或双键; *表示与噻唑环的连接点; 并且n为1,2或3.还公开了包含上述化合物的药物组合物和用于癌症和其它疾病的治疗方法。